ST. PAUL, Minn., Oct. 4, 2013 /PRNewswire/ -- Prime Therapeutics' (Prime) efforts to improve patient health and reduce health care costs were recognized on Oct. 1 at the URAC Quality Summit in Washington, D.C. Prime's Controlled Substance Drug Utilization Review (DUR) program and its......
More...
